Deutsche Bank
DTIL icon

Deutsche Bank’s Precision BioSciences DTIL Stock Holding History

Deutsche Bank’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,949
Closed -$141K – 3932
2022
Q4 		$141K Hold
3,949
– – ﹤0.01% 3157
2022
Q3 		$154K Buy
3,949
+18
+0.5% +$855 ﹤0.01% 3093
2022
Q2 		$189K Sell
3,931
-2,349
-37% -$138K ﹤0.01% 3210
2022
Q1 		$580K Sell
6,280
-157
-2% -$21.3K ﹤0.01% 2658
2021
Q4 		$1.43M Buy
6,437
+4,042
+169% +$1.13M ﹤0.01% 2217
2021
Q3 		$829K Sell
2,395
-493
-17% -$167K ﹤0.01% 2733
2021
Q2 		$1.08M Buy
2,888
+879
+44% +$264K ﹤0.01% 2711
2021
Q1 		$623K Buy
2,009
+297
+17% +$104K ﹤0.01% 2965
2020
Q4 		$429K Buy
1,712
+844
+97% +$207K ﹤0.01% 3007
2020
Q3 		$160K Buy
868
+73
+9% +$14.5K ﹤0.01% 3327
2020
Q2 		$199K Buy
795
+376
+90% +$82.3K ﹤0.01% 3147
2020
Q1 		$76K Sell
419
-24
-5% -$6.28K ﹤0.01% 3360
2019
Q4 		$184K Buy
443
+357
+415% +$112K ﹤0.01% 3277
2019
Q3 		$20K Sell
86
-308
-78% -$100K ﹤0.01% 4317
2019
Q2 		$156K Buy
+394
New +$159K ﹤0.01% 3971

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's DTIL Position: Q1 2023 in Review

Deutsche Bank sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 3,949 shares — an estimated $141K sold.

Deutsche Bank first reported a position in DTIL in Q2 2019 and held it in 15 quarters. The position peaked at $1.43M in Q4 2021. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

  • Deutsche Bank reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
  • Deutsche Bank sold 3,949 Precision BioSciences shares in Q1 2023, an estimated $141K.
  • Deutsche Bank first reported a position in Precision BioSciences in Q2 2019 and held it in 15 quarters.
  • Deutsche Bank's Precision BioSciences position peaked at $1.43M in Q4 2021.
  • 86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.